Stage IV Lung Cancer: Angie's Patient Story

Patient Info: Angie Brice Hessbruegge, Female, Under 40 | Stage IV

Angie remained on chemotherapy and focused on parenting, counseling, faith, and long-term survivor stories while living with Stage IV lung cancer.

We're Back! Q&A With Breathe Deep TOGETHER Team Captains

Patient Info: Anonymized, Female

This mother remained in ongoing lung-cancer care, managing fatigue and frequent appointments while approaching life in 3-month intervals.

Lung Cancer: Katie's Survivor Story

Patient Info: Katie Gilmore, Female

Katie recovered from successful surgery without chemotherapy or radiation and was training for her first marathon, scheduled for April 13, 2025.

Stage I Lung Adenocarcinoma: Julie's Survivor Story

Patient Info: Julie Jones, Female, 50s | Stage I

Julie resumed walking the day after VATS and completed a half marathon 53 days after surgery, finishing about 10 minutes slower than before surgery.

Diagnosed at 38, a Veteran, Living with ALK-Positive Lung Cancer: Laura's Story

Patient Info: Laura, Female, Under 40 | Stage IV

Biomarkers: ALK-positive

Three years after diagnosis, Laura remained on lorlatinib with improved energy and quality of life while continuing to live with Stage IV ALK-positive lung cancer.

GO2 FoundationRead more →

Lung Cancer: Lyn's Patient Story

Patient Info: Lyn Smith, Female

Nineteen months after diagnosis and after chemotherapy, Lyn was more at peace with lung cancer and remained cautiously optimistic while staying close to family.

Lung Cancer: Bob's Patient Story

Patient Info: Bob Neary, Male, 60s

Bob died from lung cancer in February 2013 at age 63, 7 months after diagnosis.

GO2 FoundationRead more →

Stage IV Lung Cancer: Katherine's Patient Story

Patient Info: Katherine Adelufosi, Female, Under 40 | Stage IV

After persistent self-advocacy, Katherine found a targeted medication and chemotherapy that began working, and she remained active in peer support and lung-cancer awareness.

Podcast: Why Community Matters in Lung Cancer Care

Patient Info: Jill Feldman, Female

Jill was living as a lung-cancer survivor and advocate, using community connection to cope with multiple family losses and her own diagnosis.

Turning the Tide: My Journey into Lung Cancer Advocacy

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: ALK-positive

She continued living with Stage IV ALK-positive NSCLC while advocating for research funding, traveling, and returning to tap dancing.

Stage IV ALK Lung Cancer: Michelle's Patient Story

Patient Info: Michelle, Female | Stage IV

Biomarkers: ALK-positive

Metastatic Site: leptomeninges and cerebrospinal fluid / central…

Targeted therapy and proton craniospinal irradiation eliminated detectable leptomeningeal disease. Treatment side effects later passed, and Michelle continued rehabilitation.

Stage IV EGFR Non-Small Cell Lung Cancer: Valerie's Patient Story

Patient Info: Valerie Brown, Female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion

Valerie was stable for more than 20 months on targeted therapy for Stage IV EGFR exon 19-deleted lung adenocarcinoma.

Putting Patients in the Center: Celebrating a Winning Cancer Care Team

Patient Info: Jill, Female

Jill continued working with a multidisciplinary lung-cancer team while advocating for care organized around each patient’s family, goals, and emotional well-being.

The Pervasive Stigma Associated With Lung Cancer

Patient Info: Anonymized

Biomarkers: EGFR exon 19 deletion

After right upper lobectomy and chemotherapy, the patient continued a daily targeted-therapy tablet for EGFR exon 19-deleted lung adenocarcinoma.

Finding Hope in Emerging Therapies

Patient Info: Anonymized, Under 40 | Stage IV

Metastatic Site: spine/bones, including T11 vertebra

An unnamed targeted therapy shrank all visible tumors with minimal side effects, allowing the patient to consider returning to surgical residency.

Stage IV ALK Lung Cancer: Frank's Survivor Story

Patient Info: Frank Sierawski, Male | Stage IV

Biomarkers: ALK-positive

Frank was disease-free for more than 7 years while continuing his second ALK-targeted tyrosine kinase inhibitor after lobectomy and brain radiation.

Lung Cancer: Martine's Survivor Story

Patient Info: Martine, Female, 60s

Martine was 66 and retired when she shared her lung cancer story; after chemotherapy, right lung lobectomy, and more chemotherapy, she was in remission and rebuilding an active life.

Lung Cancer: Mary's Patient Story

Patient Info: Mary, Female

Mary received 4 cycles of chemotherapy, then radiotherapy and a clinical trial for lung cancer, while using MyChristie-MyHealth questionnaires to keep her clinical team updated between visits.

The Christie NHSRead more →

Lung Cancer: Katia's Survivor Story

Patient Info: Katia, Female, 40s

Katia had a cancerous lung nodule removed with partial left lung surgery in January 2015 and continued yearly imaging surveillance afterward.

Alexia caregiver story: Liz in complete remission after lung cancer treatment

Patient Info: Liz, Female

Alexia described her mother Liz as being in complete remission after a long lung cancer treatment period that ended in October 2016.

Small Cell Lung Cancer: François's Patient Story

Patient Info: François, Male, 60s

Françoise described supporting her husband François through small cell lung cancer and returning each year for hospital monitoring with CT and MRI scans.

Lung Cancer: Liz's Patient Story

Patient Info: Liz, Female

Jacques described Liz in her first year of recovery after lung cancer treatment that involved surgery and chemotherapy, with the couple beginning a new phase of life afterward.

Stage IV Lung Cancer: Agnès's Patient Story

Patient Info: Agnès, Female, 50s | Stage IV

Biomarkers: Tumor mutation identified; specific alteration not named

Agnès had metastatic lung cancer with a tumor mutation that allowed home-based treatment; her breathing and mobility improved and some metastases and one nodule disappeared.

Non-Small Cell Lung Cancer: Jode's Patient Story

Patient Info: Jode, Male

Jode’s husband had non-small cell lung cancer diagnosed in 2010, received 33 chemotherapy cycles over 1 year, and later continued 6-monthly oncology and pulmonology follow-up.